Brief: Amneal Pharma To Settle Majority Of Opioids-Related Claims
28/01/2026 21:26
Jan 28 (Reuters) - Amneal Pharmaceuticals Inc AMRX.O: AMNEAL PHARMA - TO SETTLE MAJORITY OF OPIOIDS-RELATED CLAIMS - SEC FILING AMNEAL PHARMA - OPIOIDS SETTLEMENT AGREEMENT EFFECTIVE JANUARY 29, 2026 - SEC FILING AMNEAL PHARMA - TO PAY $88.5 MILLION UNDER OPIOIDS SETTLEMENT - SEC FILING AMNEAL PHARMA - TO PROVIDE $177.4 MILLION IN NALOXONE NASAL SPRAY TO HELP TREAT OPIOID OVERDOSES - SEC FILING Further company coverage: AMRX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amneal Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-3M Company, Constellation Energy, Metropolitan Bank Holding
US FDA is working with manufacturers to boost estrogen patch supply amid access concerns (updated)
U.S. RESEARCH ROUNDUP- Intuit, MongoDB, Zscaler
U.S. STOCKS ON THE MOVE-Mastercard, Yum, Equinix
Amneal Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary